CIT Healthcare has served as Sole Lead Arranger in a $15.5 million senior secured credit facility to DeVilbiss Healthcare, a medical device company and a portfolio company of Vestar Capital Partners. Proceeds of the facility will be used to refinance debt, bolster working capital and for new equipment purchases.
“This transaction highlights our expertise and experience in working with private equity firms to meet the financing needs of their middle market healthcare portfolio companies,” said Michael Coiley, Managing Director of CIT Healthcare. “We are pleased to have provided this financing, which will allow DeVilbiss Healthcare to grow their business.”
DeVilbiss Healthcare designs, develops, manufactures and markets medical products that address the respiratory needs of patients in institutional and homecare settings. Primary product lines include sleep therapy, pulmonary drug delivery, stationary and portable supplemental oxygen, homecare suction devices, and ENT (ear, nose and throat) professional instruments. DeVilbiss products are manufactured in the United States, Europe and Asia and are distributed in more than 100 countries around the world. The company is headquartered in Somerset, PA in a 152,000,000-square-foot facility which houses manufacturing, distribution and warehouse space (www.devilbisshealthcare.com).
“CIT presented a tailored financing structure that met our goals and will allow us to continue to invest in manufacturing and product development. This deal positions us well for future growth and will help create 20 new jobs in Pennsylvania. We look forward to building on our relationship with CIT,” said Ed Murphy, CEO of DeVilbiss Healthcare.
Vestar specializes in management buyouts and growth capital investments. The firm targets companies in the US and Europe with valuations of $150 million to $1.5 billion and operations in four industry sectors: consumer; diversified industries; healthcare; and financial services. Since the firm’s founding in 1988, the Vestar funds have completed more than 69 investments in companies with a total value of more than $30 billion. Vestar, with $8 billion in capital under management, has offices in New York, Boston, and Denver (www.vestarcapital.com).
“For more than two decades, we have worked with talented management teams to grow their businesses. This financing will allow DeVilbiss Healthcare to continue to grow as it develops products that meet the respiratory needs of patients in institutional and homecare settings throughout the world,” said Chris Durbin, Managing Director at Vestar Capital Partners.
CIT is a bank holding company with more than $33 billion in assets. Sectors of interest include small business and middle market lending, factoring, retail finance, aerospace, equipment and rail leasing, and vendor finance. CIT was founded in 1908 and is based in New York (www.cit.com).
© 2012 PEPD • Private Equity’s Leading News Magazine • 12-17-12